Salutary Effects of Nutritional Ketosis for the Diseased Human Heart

Volek JS, Phinney SD, Krauss RM, Johnson RJ, Saslow LR, Gower B, et al. Alternative dietary patterns for Americans: low-carbohydrate diets. Nutrients. 2021;13: 13:3299.

Article  PubMed  Google Scholar 

Gormsen LC, Svart M, Thomsen HH, Søndergaard E, Vendelbo MH, Christensen N, et al. Ketone body infusion with 3-hydroxybutyrate reduces myocardial glucose uptake and increases blood flow in humans: a positron emission tomography study. J Am Heart Assoc. 2017;6: e005066.

Article  PubMed  PubMed Central  Google Scholar 

Nielsen R, Møller N, Gormsen LC, Tolbod LP, Hansson NH, Sorensen J, et al. Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients. Circulation. 2019;139:2129–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lopaschuk GD, Ussher JR, Folmes CDL, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90:207–58.

Article  CAS  PubMed  Google Scholar 

Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol. 1974;36:413–59.

Article  CAS  PubMed  Google Scholar 

Pascual F, Coleman RA. Fuel availability and fate in cardiac metabolism: a tale of two substrates. Biochim Biophys Acta. 2016;1860:1425–33.

Article  PubMed Central  Google Scholar 

Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev. 2005;85:1093–129.

Article  CAS  PubMed  Google Scholar 

Kolwicz SC Jr. An exercise in cardiac metabolism. Front Cardiovasc Med. 2018;5: 66.

Yurista SR, Chong C-R, Badimon JJ, Kelly DP, de Boer RA, Westenbrink BD. Therapeutic potential of ketone bodies for patients with cardiovascular disease: JACC State-of-the-Art review. J Am Coll Cardiol. 2021;77:1660–9.

Article  CAS  PubMed  Google Scholar 

Yurista SR, Nguyen CT, Rosenzweig A, de Boer RA, Westenbrink BD. Ketone bodies for the failing heart: fuels that can fix the engine? Trends Endocrinol Metab. 2021;32:814–26.

Article  CAS  PubMed  Google Scholar 

Gerdes AM, Capasso JM. Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure. J Mol Cell Cardiol. 1995;27:849–56.

Article  CAS  PubMed  Google Scholar 

Bertero E, Maack C. Metabolic remodelling in heart failure. Nat Rev Cardiol. 2018;15:457–70.

Article  CAS  PubMed  Google Scholar 

Neglia D, De Caterina A, Marraccini P, Natali A, Ciardetti M, Vecoli C, et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2007;293:H3270–8.

Article  CAS  PubMed  Google Scholar 

Voros G, Ector J, Garweg C, Droogne W, Van Cleemput J, Peersman N, et al. Increased cardiac uptake of ketone bodies and free fatty acids in human heart failure and hypertrophic left ventricular remodeling. Circ Heart Fail. 2018;11: e004953.

Article  CAS  PubMed  Google Scholar 

Chandler MP, Kerner J, Huang H, Vazquez E, Reszko A, Martini WZ, et al. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol Heart Circ Physiol. 2004;287:H1538–43.

Article  CAS  PubMed  Google Scholar 

Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation. 1996;94:2837–42.

Article  CAS  PubMed  Google Scholar 

Lionetti V, Stanley WC, Recchia FA. Modulating fatty acid oxidation in heart failure. Cardiovasc Res. 2011;90:202–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carley AN, Maurya SK, Fasano M, Wang Y, Selzman CH, Drakos SG, et al. Short-chain fatty acids outpace ketone oxidation in the failing heart. Circulation. 2021;143:1797–808.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fillmore N, Levasseur JL, Fukushima A, Wagg CS, Wang W, Dyck JRB, et al. Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction. Mol Med. 2018;24: 3.

Article  PubMed  PubMed Central  Google Scholar 

ávila-RVG D, Vedala G, Herrero P, de las FL, Rogers JG, Kelly DP, et al. Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2002;40:271–7.

Article  Google Scholar 

Yazaki Y, Isobe M, Takahashi W, Kitabayashi H, Nishiyama O, Sekiguchi M, et al. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course. Heart. 1999;81:153–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murashige D, Jang C, Neinast M, Edwards JJ, Cowan A, Hyman MC, et al. Comprehensive quantification of fuel use by the failing and nonfailing human heart. Science. 2020;370:364–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swan JW, Anker SD, Walton C, Godsland IF, Clark AL, Leyva F, et al. Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J Am Coll Cardiol. 1997;30:527–32.

Article  CAS  PubMed  Google Scholar 

Riehle C, Abel ED. Insulin signaling and heart failure. Circ Res. 2016;118:1151–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abel ED, O’Shea KM, Ramasamy R. Insulin resistance: metabolic mechanisms and consequences in the heart. Arteriosclerosis, thrombosis, and vascular biology. 2012;32:2068–76

Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25:262–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Halestrap AP. Pyruvate and ketone-body transport across the mitochondrial membrane. Exchange properties, pH-dependence and mechanism of the carrier. Biochem J. 1978;172:377–87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yurista SR, Chen S, Welsh A, Tang WHW, Nguyen CT. Targeting myocardial substrate metabolism in the failing heart: ready for prime time?? Curr Heart Fail Rep. 2022;19:180–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cotter DG, Schugar RC, Crawford PA. Ketone body metabolism and cardiovascular disease. Am J Physiol Heart Circ Physiol. 2013;304:H1060-76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monzo L, Sedlacek K, Hromanikova K, Tomanova L, Borlaug BA, Jabor A, et al. Myocardial ketone body utilization in patients with heart failure: the impact of oral ketone ester. Metabolism. 2021;115: 154452.

Article  CAS  PubMed  Google Scholar 

Lopaschuk GD, Verma S. Empagliflozin’s fuel hypothesis: not so soon. Cell Metab. 2016;24:200–2.

Article  CAS  PubMed  Google Scholar 

Steenbergen C, Deleeuw G, Rich T, Williamson JR. Effects of acidosis and ischemia on contractility and intracellular pH of rat heart. Circ Res. 1977;41:849–58.

Article 

Comments (0)

No login
gif